Huiying Qiu

机构：Shanghai Jiao Tong University, Soochow University, Tongren Hospital, National Clinical Research, Shanghai First People's Hospital, First Affiliated Hospital of Soochow University · ORCID：0000-0002-1014-2403

发表论文 201 篇 · 总被引 1022 次 · h-index 20

代表论文

• Efficacy of venetoclax combined with homoharringtonine and cytarabine for younger adults with newly diagnosed AML (2025 · Annals of Hematology · 被引 3)
• Age- and comorbidity-adjusted busulfan, fludarabine, cytarabine, and low-dose TBI-based conditioning regimen is effective for myelodysplastic syndromes with excess blasts undergoing allogeneic peripheral blood stem cell transplantation (2025 · Cell Transplantation · 被引 2)
• DEK facilitates bortezomib resistance of multiple myeloma by modulating ferroptosis (2025 · Clinical and Experimental Medicine · 被引 2)
• A lower-intensity, venetoclax-containing protocol is effective in adults with newly diagnosed mixed-phenotype acute leukemia (2026 · Haematologica · 被引 1)
• Supplementary Table S4 from Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with <i>De Novo</i> Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Trial (2026)
• Supplementary Table S3 from Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with <i>De Novo</i> Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Trial (2026)